Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Neuroone Medical Technologies (NMTC) Long-Term Debt Issuances (2016 - 2020)

Historic Long-Term Debt Issuances for Neuroone Medical Technologies (NMTC) over the last 7 years, with Q4 2020 value amounting to $5.0 million.

  • Neuroone Medical Technologies' Long-Term Debt Issuances changed N/A to $5.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $142427.0, marking a year-over-year change of. This contributed to the annual value of $8.4 million for FY2020, which is N/A changed from last year.
  • Per Neuroone Medical Technologies' latest filing, its Long-Term Debt Issuances stood at $5.0 million for Q4 2020.
  • Neuroone Medical Technologies' 5-year Long-Term Debt Issuances high stood at $5.0 million for Q4 2020, and its period low was -$4.5 million during Q2 2017.
  • For the 3-year period, Neuroone Medical Technologies' Long-Term Debt Issuances averaged around $23361.9, with its median value being $8210.0 (2016).
  • Per our database at Business Quant, Neuroone Medical Technologies' Long-Term Debt Issuances skyrocketed by 24329.86% in 2016 and then plummeted by 5510364.19% in 2017.
  • Neuroone Medical Technologies' Long-Term Debt Issuances (Quarter) stood at $21106.0 in 2016, then tumbled by 2631.04% to -$534201.0 in 2017, then skyrocketed by 1035.98% to $5.0 million in 2020.
  • Its last three reported values are $5.0 million in Q4 2020, -$534201.0 for Q3 2017, and -$4.5 million during Q2 2017.